Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir

By de Niet A.   Takkenberg R.B.   Benayed R.   Riley-Gillis B.   Weegink C.J.   Zaaijer H.L.   Koot M.   Jansen P.L.M.   Beld M.G.H.M.   Lopatin U.   Reesink H.W.  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 475-481

Informa Healthcare

Access to resources Recommend Favorite

Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients

By  

Digestion, Vol. 84, Iss. 1, 2011-12 ,pp. : 23-28

Karger

Access to resources Recommend Favorite

From Trials to a Real Hospital Setting: Effectiveness of Pegylated Interferon-α-2b/Ribavirin Combination Therapy for Naïve Chronic Hepatitis C Patients

By Piai Guido   Scalice Elisa   Focareta Rosaria   Terracciano Fulvia   Filippo Francesca   Forte Giovambattista  

Digestive Diseases and Sciences, Vol. 51, Iss. 9, 2006-09 ,pp. : 1619-1626

Springer Publishing Company

Access to resources Recommend Favorite

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

By Nakagawa Mina   Sakamoto Naoya   Ueyama Mayumi   Mogushi Kaoru   Nagaie Satoshi   Itsui Yasuhiro   Azuma Seishin   Kakinuma Sei   Tanaka Hiroshi   Enomoto Nobuyuki   Watanabe Mamoru  

Journal of Gastroenterology, Vol. 45, Iss. 6, 2010-06 ,pp. : 656-665

Springer Publishing Company

Access to resources Recommend Favorite

Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype C

By Asahina Y.   Izumi N.   Uchihara M.   Noguchi O.   Nishimura Y.   Inoue K.   Ueda K.   Tsuchiya K.   Hamano K.   Itakura J.   Miyake S.  

Journal of Hepatology, Vol. 39, Iss. 6, 2003-12 ,pp. : 1063-1069

Elsevier

Access to resources Recommend Favorite